BioElectronics Expands into Tesco in the UK Market
The leading grocery retailer now stocks ActiPatch(R) Pain Therapy
(firmenpresse) - FREDERICK, MD -- (Marketwired) -- 05/17/17 -- BioElectronics Corporation (OTC PINK: BIEL), is the maker of advanced, drug-free, pain management medical devices.
The Company is pleased to announce that Tesco has placed their initial order for BioElectronics' ActiPatch® Musculoskeletal Pain Therapy devices. "We are looking forward to collaborating with this innovative retailer," said Christopher Russell, VP of Sales, BioElectronics Corporation.
About Tesco
Tesco PLC, () is a British multi-national company that specializes in the merchandise and grocery retail chain markets. It is the third largest retailer in the world, measured by profits and has over 3,000 stores in the U.K. alone. Founded in 1919, Tesco has diversified its offerings since the 1990's and is now present in 8 countries across Asia and Europe. As of 2016/2017, Tesco reported revenue of $72 billion.
About BioElectronics Corporation
BioElectronics Corporation is a leader in non-invasive electroceuticals and the maker of an industry leading family of electroceutical devices: ActiPatch® Therapy, over-the-counter treatment for back pain and other musculoskeletal complaints; RecoveryRx® Devices for chronic and post-operative wound care; Allay® Menstrual Pain Therapy. For more information, please visit .
Paul Knopick
940-262-3584
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 17.05.2017 - 15:31 Uhr
Sprache: Deutsch
News-ID 543055
Anzahl Zeichen: 0
contact information:
Town:
FREDERICK, MD
Kategorie:
Alternative
Diese Pressemitteilung wurde bisher 153 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"BioElectronics Expands into Tesco in the UK Market"
steht unter der journalistisch-redaktionellen Verantwortung von
BioElectronics Corporation (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
